Back to News
Market Impact: 0.35
Humana Boosts FY26 Outlook
Source: Nasdaq
Corporate EarningsCorporate Guidance & OutlookHealthcare & Biotech
Humana raised its full-year 2026 earnings and adjusted earnings guidance while reporting third-quarter financial results. The article provides no revised forecasts or financial figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
HUM0.65
More News
- Humana lifts annual profit forecast as medical costs ease
- Raymond James reiterates Humana stock rating on Q3 beat
- CVS and UnitedHealth lost ground on Medicare ratings. Who gained?
- Further turmoil could be in store for tech stocks. What to watch in the week ahead
- Tech stock rout, driven by US AI fears, continues in Asian trading
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production